| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 11.621 | 3.886 | 0 | 0 | 3.024 | 4.056 | 0 | 0 |
| Total Income - EUR | - | - | 11.621 | 3.886 | 0 | 0 | 3.024 | 4.056 | 0 | 0 |
| Total Expenses - EUR | - | - | 345 | 924 | 625 | 111 | 1.196 | 4.360 | 197 | 0 |
| Gross Profit/Loss - EUR | - | - | 11.276 | 2.962 | -625 | -111 | 1.829 | -304 | -197 | 0 |
| Net Profit/Loss - EUR | - | - | 10.927 | 2.845 | -625 | -111 | 1.740 | -414 | -197 | 0 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Axa Promomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 11.580 | 3.560 | 6 | 47 | 1.566 | 96 | 18 | 17 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 1.980 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | 9.600 | 3.560 | 6 | 47 | 1.566 | 96 | 18 | 17 |
| Shareholders Funds | - | - | 10.971 | 2.961 | -511 | -612 | 1.142 | -305 | -501 | -498 |
| Social Capital | - | - | 44 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | - | - | 609 | 599 | 517 | 659 | 425 | 400 | 518 | 515 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
7311
|
|||||||||
Comments - Axa Promomed Srl